Page last updated: 2024-10-21

urea and Breast Cancer

urea has been researched along with Breast Cancer in 58 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Research Excerpts

ExcerptRelevanceReference
"Patients with GI tumors or breast cancer treated with capecitabine were included in this randomized phase III study."9.20Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group. ( Al-Batran, SE; Bolz, G; Gencer, D; Hegewisch-Becker, S; Hofheinz, RD; Kronawitter, U; Loeffler, LM; Potenberg, J; Schneeweiss, A; Schulz, H; Stahl, M; Tauchert, F, 2015)
"We recently developed a novel aryl-urea fatty acid (CTU; 16({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid) that impaired the viability of MDA-MB-231 breast cancer cells in vitro and in mouse xenograft models in vivo."7.91Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells. ( Al-Zubaidi, Y; Bourget, K; Chen, Y; Choucair, H; Koolaji, N; Murray, M; Pazderka, C; Rahman, MK; Rawling, T; Umashankar, B, 2019)
"In an attempt to improve anti-breast cancer activity, a new series of 4-piperazinylquinoline derivatives based on the urea/thiourea scaffold were designed and synthesised by a pharmacophore hybrid approach."7.91Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. ( Lee, H; Pundir, S; Viswas, RS, 2019)
" We synthesized arylurea fatty acids and found that the analogue 16-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid (13b) decreased proliferation and activated apoptosis in MDA-MB-231 breast cancer cells in vitro and in vivo."7.85A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin To Promote Killing of Breast Cancer Cells. ( Allison, SE; Bourget, K; Chen, YJ; Choucair, H; Dunstan, CR; Koolaji, N; Murray, M; Rawling, T, 2017)
"Dantrolene (1) is a substrate for breast cancer resistant protein, which is widely distributed in the blood-brain-barrier, intestine, gall bladder, and liver."7.78Radiosynthesis of [13N]dantrolene, a positron emission tomography probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia. ( Fujinaga, M; Fukumura, T; Kumata, K; Nengaki, N; Ogawa, M; Suzuki, K; Takei, M; Yoshida, Y; Zhang, MR, 2012)
"Female breast cancer has become the most commonly diagnosed cancer worldwide."5.72Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative. ( Chen, K; Sarwar, A; Su, Q; Wang, J; Wu, Q; Zhang, Y, 2022)
"Family history of breast cancer, body mass index, systolic hypertension, comorbidity, residence and menopausal status were significantly associated with hyperglycemia, uremia and hyperuricemia."5.72Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study. ( Fasil, A; Kebede, T; Melak, T; Sina, AA, 2022)
"Breast cancer is the most frequently diagnosed cancer and the second leading cause of cancer related deaths among women worldwide."5.43Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways. ( Machado, VA; Peixoto, D; Queiroz, MJ; Soares, R, 2016)
"Patients with GI tumors or breast cancer treated with capecitabine were included in this randomized phase III study."5.20Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group. ( Al-Batran, SE; Bolz, G; Gencer, D; Hegewisch-Becker, S; Hofheinz, RD; Kronawitter, U; Loeffler, LM; Potenberg, J; Schneeweiss, A; Schulz, H; Stahl, M; Tauchert, F, 2015)
"To evaluate the effectiveness of "intensive use" of the lotion containing 3% urea, polidocanol and hyaluronic acid for preventing the appearance of acute radiodermatitis and controlling its severity."5.14Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. ( Alvarado Astudillo, A; Hernández Armenteros, ML; Macías Hernández, V; Mirada Ferre, A; Murcia Mejía, M; Pardo Masferrer, J; Soto Pérez, R; Vidal Fernández, M, 2010)
"We recently developed a novel aryl-urea fatty acid (CTU; 16({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid) that impaired the viability of MDA-MB-231 breast cancer cells in vitro and in mouse xenograft models in vivo."3.91Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells. ( Al-Zubaidi, Y; Bourget, K; Chen, Y; Choucair, H; Koolaji, N; Murray, M; Pazderka, C; Rahman, MK; Rawling, T; Umashankar, B, 2019)
"In an attempt to improve anti-breast cancer activity, a new series of 4-piperazinylquinoline derivatives based on the urea/thiourea scaffold were designed and synthesised by a pharmacophore hybrid approach."3.91Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. ( Lee, H; Pundir, S; Viswas, RS, 2019)
" We synthesized arylurea fatty acids and found that the analogue 16-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid (13b) decreased proliferation and activated apoptosis in MDA-MB-231 breast cancer cells in vitro and in vivo."3.85A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin To Promote Killing of Breast Cancer Cells. ( Allison, SE; Bourget, K; Chen, YJ; Choucair, H; Dunstan, CR; Koolaji, N; Murray, M; Rawling, T, 2017)
"Dantrolene (1) is a substrate for breast cancer resistant protein, which is widely distributed in the blood-brain-barrier, intestine, gall bladder, and liver."3.78Radiosynthesis of [13N]dantrolene, a positron emission tomography probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia. ( Fujinaga, M; Fukumura, T; Kumata, K; Nengaki, N; Ogawa, M; Suzuki, K; Takei, M; Yoshida, Y; Zhang, MR, 2012)
"Female breast cancer has become the most commonly diagnosed cancer worldwide."1.72Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative. ( Chen, K; Sarwar, A; Su, Q; Wang, J; Wu, Q; Zhang, Y, 2022)
"Family history of breast cancer, body mass index, systolic hypertension, comorbidity, residence and menopausal status were significantly associated with hyperglycemia, uremia and hyperuricemia."1.72Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study. ( Fasil, A; Kebede, T; Melak, T; Sina, AA, 2022)
"Breast cancer is the most frequently diagnosed cancer and the second leading cause of cancer related deaths among women worldwide."1.43Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways. ( Machado, VA; Peixoto, D; Queiroz, MJ; Soares, R, 2016)
"Breast cancer is the most common malignant disease occurring in women and represents a substantial proportion of the global cancer burden."1.43Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. ( Cho, JH; Choi, HG; Kim, CY; Kim, D; Kim, HK; Kim, ND; Ko, E; Lee, C; Lee, SH; Nan, HY; Park, JS; Son, JB; Yoon, S, 2016)
" The results of cytotoxicity and flow cytometry data showed that the compounds had a moderate to strong effect against MCF-7 and HepG2 cells and were less toxic to HEK293 cells."1.42Novel all trans-retinoic Acid derivatives: cytotoxicity, inhibition of cell cycle progression and induction of apoptosis in human cancer cell lines. ( Al-Khedhairy, AA; Al-Oqail, MM; Al-Sheddi, ES; Farshori, NN; Musarrat, J; Saquib, Q; Siddiqui, MA, 2015)
"Patients with triple-negative breast cancer (TNBC) - defined by lack of estrogen receptor and progesterone receptor expression as well as lack of human epidermal growth factor receptor 2 (HER2) amplification - have a poor prognosis."1.38Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. ( Aft, RL; Cai, S; Ellis, MJ; Goiffon, RJ; Guo, Z; Hoog, J; Li, S; Lin, L; Ma, CX; Piwnica-Worms, H; Prat, A; Ryan, CE; Schaiff, WT, 2012)
" It was able to inhibit the biomarker phosphorylation for 8h when dosed at 25 mg/kg iv."1.365-ureidobenzofuranone indoles as potent and efficacious inhibitors of PI3 kinase-alpha and mTOR for the treatment of breast cancer. ( Anderson, JT; Ayral-Kaloustian, S; Brooijmans, N; Das, S; Hollander, I; Lucas, J; Mallon, R; Nguyen, T; Venkatesan, AM; Yu, K; Zhang, N, 2010)
"In both MCF-7 and T47D human breast cancer cells, we have observed marked differences in the sedimentation properties of the PR on high salt sucrose gradients: while the R5020-receptor complexes sediment at approximately 4 S (4."1.27Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells. ( Katzenellenbogen, BS; Mullick, A, 1986)
"However, in the patients with possible protein deficiency and normal renal function, an elevation of plasma ribonuclease is, in general, associated with a decrease in serum albumin, transferrin and cholinesterase."1.26An assessment of the clinical usefulness of plasma ribonuclease assays. ( Citrin, DL; Rowan, RM; Shenkin, A, 1976)

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-199016 (27.59)18.7374
1990's4 (6.90)18.2507
2000's3 (5.17)29.6817
2010's28 (48.28)24.3611
2020's7 (12.07)2.80

Authors

AuthorsStudies
Su, Q2
Wu, Q2
Chen, K2
Wang, J6
Sarwar, A1
Zhang, Y6
Huynh, TYL1
Oscilowska, I1
Sáiz, J1
Nizioł, M1
Baszanowska, W1
Barbas, C1
Palka, J1
Tabata, M1
Khamhanglit, C1
Kotaki, S1
Miyahara, Y1
Kebede, T2
Melak, T2
Sina, AA2
Fasil, A2
Zorc, B2
Rajić, Z1
Perković, I2
Murray, M3
Roseblade, A1
Chen, Y7
Bourget, K3
Rawling, T3
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y4
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X11
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B2
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y3
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X2
Zhou, L2
Dong, X2
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Zhang, E1
Zhang, J4
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J9
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C2
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L3
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X2
Zhao, Q1
Hu, W1
Wu, X1
Lu, J2
Li, M1
Li, W3
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S2
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y2
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K2
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y5
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y2
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S2
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H3
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y2
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X2
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S2
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G2
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J3
Qian, Y2
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Qu, Z1
Yang, Z1
Jia, X1
Lin, Y1
He, Q1
Luo, Y1
Lv, J1
Ni, X1
Amara, S1
Majors, C1
Roy, B1
Hill, S1
Rose, KL1
Myles, EL1
Tiriveedhi, V1
Choucair, H2
Koolaji, N2
Allison, SE1
Chen, YJ1
Dunstan, CR1
Sun, Q1
Song, L1
Liu, F2
Barbosa, FAR1
Siminski, T1
Canto, RFS1
Almeida, GM1
Mota, NSRS1
Ourique, F1
Pedrosa, RC1
Braga, AL1
El-Naggar, M1
Almahli, H1
Ibrahim, HS2
Eldehna, WM2
Abdel-Aziz, HA2
Ma, F1
Xu, W1
Li, L1
Al-Zubaidi, Y1
Pazderka, C1
Rahman, MK1
Umashankar, B1
Viswas, RS1
Pundir, S1
Lee, H1
Singh, S1
Supuran, CT1
Al-Sheddi, ES1
Al-Oqail, MM1
Saquib, Q1
Siddiqui, MA1
Musarrat, J1
Al-Khedhairy, AA1
Farshori, NN1
Hofheinz, RD1
Gencer, D1
Schulz, H1
Stahl, M1
Hegewisch-Becker, S1
Loeffler, LM1
Kronawitter, U1
Bolz, G1
Potenberg, J1
Tauchert, F1
Al-Batran, SE1
Schneeweiss, A1
Wang, P1
Jing, Q1
Yue, J1
Cheng, Z1
Liu, R1
Machado, VA1
Peixoto, D1
Queiroz, MJ1
Soares, R1
Lai, J1
Du, Z1
Gao, J1
Gorityala, S1
Xiong, X1
Deng, O1
Ma, Z2
Yan, C1
Susana, G1
Fares, M1
Alsherbiny, MA1
Aly, MH1
Ghabbour, HA1
Antunović, M1
Marijanović, I1
Pavić, K1
Ester, K1
Kralj, M1
Vlainić, J1
Kosalec, I1
Schols, D1
Hadjipavlou-Litina, D1
Pontiki, E1
Park, JS1
Lee, C1
Kim, HK1
Kim, D1
Son, JB1
Ko, E1
Cho, JH1
Kim, ND1
Nan, HY1
Kim, CY1
Yoon, S1
Lee, SH1
Choi, HG1
Nam, H1
Chung, BC1
Lee, K1
Lee, D1
Pardo Masferrer, J1
Murcia Mejía, M1
Vidal Fernández, M1
Alvarado Astudillo, A1
Hernández Armenteros, ML1
Macías Hernández, V1
Soto Pérez, R1
Mirada Ferre, A1
Zhang, N1
Ayral-Kaloustian, S1
Anderson, JT1
Nguyen, T1
Venkatesan, AM1
Brooijmans, N1
Lucas, J1
Hollander, I1
Mallon, R1
Kumata, K1
Ogawa, M1
Takei, M1
Fujinaga, M1
Yoshida, Y1
Nengaki, N1
Fukumura, T1
Suzuki, K1
Zhang, MR1
Sanphanya, K1
Wattanapitayakul, SK1
Prangsaengtong, O1
Jo, M1
Koizumi, K1
Shibahara, N1
Priprem, A1
Fokin, VV1
Vajragupta, O1
Schoppy, DW1
Brown, EJ1
Ma, CX1
Cai, S1
Ryan, CE1
Guo, Z1
Schaiff, WT1
Lin, L1
Hoog, J1
Goiffon, RJ1
Prat, A1
Aft, RL1
Ellis, MJ1
Piwnica-Worms, H1
Aarts, M1
Sharpe, R1
Garcia-Murillas, I1
Gevensleben, H1
Hurd, MS1
Shumway, SD1
Toniatti, C1
Ashworth, A1
Turner, NC1
Yao, G1
Gao, S1
Patel, RA1
Forinash, KD1
Pireddu, R1
Sun, N1
Martin, MP1
Schönbrunn, E1
Lawrence, NJ1
Sebti, SM1
SEARS, ME1
SEGALOFF, A1
WEETH, JB1
CUNINGHAM, M1
MEYER, KK1
Gable, KL1
Maddux, BA1
Penaranda, C1
Zavodovskaya, M1
Campbell, MJ1
Lobo, M1
Robinson, L1
Schow, S1
Kerner, JA1
Goldfine, ID1
Youngren, JF1
Zhou, Y1
Inaba, S1
Liu, J1
Franke, WW1
Schiller, DL1
Hatzfeld, M1
Winter, S1
Eckert, RL1
Katzenellenbogen, BS2
Smellie, WJ1
Dean, CJ1
Sacks, NP1
Zalutsky, MR1
Garg, PK1
Carnochan, P1
Eccles, SA1
Kent, LL1
Hull-Campbell, NE1
Lau, T1
Wu, JC1
Thompson, SA1
Nori, M1
Buzin, CH1
Tang, SH1
Scaringe, WA1
Sommer, SS1
Teller, MN1
Stock, CC1
Hellman, L1
Mountain, IM1
Bowie, M1
Rosenberg, BJ1
Boyar, RM1
Budinger, JM1
Carson, JA1
Gormican, A1
Gorshein, D1
Shenkin, A1
Citrin, DL1
Rowan, RM1
Delcuve, GP1
Davie, JR1
Mullick, A1
Thalassinos, N1
Joplin, GF1
Marsh, JC1
DeConti, RC1
Hubbard, SP1
Dohan, PH1
Yamashita, K1
Larsen, PR1
Davis, B1
Deftos, L1
Field, JB1
Rothbard, S1
Watson, RF1
Zilva, JF1
Nicholson, JP1
Ahmann, DL1
Hahn, RG1
Bisel, HF1
Fennelly, JJ1
Dunne, J1
McGeeney, K1
Chong, L1
FitzGerald, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II, Randomised Controlled Trial to Evaluate the Efficacy and Safety of Moisturising Creams With or Without Palm-oil-derived Vitamin E Concentrate in Addition to Urea-based Cream or Urea-based Cream Alone in Capecitabine-associated Palmar-Plantar E[NCT05939726]90 participants (Anticipated)Interventional2023-05-16Recruiting
A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer[NCT01626781]0 participants Expanded AccessNo longer available
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for urea and Breast Cancer

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Cancer research, 1977, Volume: 37, Issue:11

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetonitriles; Androstanols; Animals; Breast Neoplasms; Bromocript

1977

Trials

4 trials available for urea and Breast Cancer

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22

    Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Antioxidants; Breast Neopla

2015
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22

    Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Antioxidants; Breast Neopla

2015
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22

    Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Antioxidants; Breast Neopla

2015
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22

    Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Antioxidants; Breast Neopla

2015
Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2010, Volume: 12, Issue:1

    Topics: Administration, Topical; Breast Neoplasms; Combined Modality Therapy; Emollients; Female; Follow-Up

2010
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:5

    Topics: Adenocarcinoma; Adenoma, Islet Cell; Adolescent; Adrenal Gland Neoplasms; Adult; Alkylating Agents;

1971

Other Studies

53 other studies available for urea and Breast Cancer

ArticleYear
Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative.
    Molecular biology reports, 2022, Volume: 49, Issue:2

    Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Autophagy; Biphenyl Compounds; Breast Neoplasms; Cell H

2022
Metformin Treatment or PRODH/POX-Knock out Similarly Induces Apoptosis by Reprograming of Amino Acid Metabolism, TCA, Urea Cycle and Pentose Phosphate Pathway in MCF-7 Breast Cancer Cells.
    Biomolecules, 2021, 12-15, Volume: 11, Issue:12

    Topics: Apoptosis; Breast Neoplasms; Chromatography, Liquid; Female; Gene Expression Regulation, Neoplastic;

2021
Detection of cell membrane proteins using ion-sensitive field effect transistors combined with chemical signal amplification.
    Chemical communications (Cambridge, England), 2022, Jun-30, Volume: 58, Issue:53

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Membrane Proteins; Receptor, ErbB-2; Transistors

2022
Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study.
    Ethiopian journal of health sciences, 2022, Volume: 32, Issue:6

    Topics: Breast Neoplasms; Cross-Sectional Studies; Female; Glucose; Humans; Tertiary Care Centers; Urea; Uri

2022
Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study.
    Ethiopian journal of health sciences, 2022, Volume: 32, Issue:6

    Topics: Breast Neoplasms; Cross-Sectional Studies; Female; Glucose; Humans; Tertiary Care Centers; Urea; Uri

2022
Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study.
    Ethiopian journal of health sciences, 2022, Volume: 32, Issue:6

    Topics: Breast Neoplasms; Cross-Sectional Studies; Female; Glucose; Humans; Tertiary Care Centers; Urea; Uri

2022
Assessment of Serum Uric Acid, Urea, and Glucose Levels and Associated Factors among Breast Cancer Patients Attending A Tertiary Hospital in Bahirdar, Ethiopia: A Comparative Cross-Sectional Study.
    Ethiopian journal of health sciences, 2022, Volume: 32, Issue:6

    Topics: Breast Neoplasms; Cross-Sectional Studies; Female; Glucose; Humans; Tertiary Care Centers; Urea; Uri

2022
Antiproliferative evaluation of various aminoquinoline derivatives.
    Acta pharmaceutica (Zagreb, Croatia), 2019, Dec-01, Volume: 69, Issue:4

    Topics: Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colo

2019
Carbon Chain Length Modulates MDA-MB-231 Breast Cancer Cell Killing Mechanisms by Mitochondrially Targeted Aryl-Urea Fatty Acids.
    ChemMedChem, 2020, 01-17, Volume: 15, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbon; Cell Cycle; Cell Proliferation; Cell Sur

2020
Causal Associations between Serum Urea and Cancer: A Mendelian Randomization Study.
    Genes, 2021, 03-29, Volume: 12, Issue:4

    Topics: Breast Neoplasms; Carcinoma, Renal Cell; Female; Genome-Wide Association Study; Humans; Kidney Neopl

2021
Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Checkpoi

2017
Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclins; Enzyme-Linked Immunosorbent Assay;

2017
A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin To Promote Killing of Breast Cancer Cells.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Fatty Acids; Female; Humans; Mice; Mitochond

2017
Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
    European journal of medicinal chemistry, 2017, Dec-01, Volume: 141

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug

2017
Novel pyrimidinic selenourea induces DNA damage, cell cycle arrest, and apoptosis in human breast carcinoma.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; DNA

2018
Pyridine-Ureas as Potential Anticancer Agents: Synthesis and In Vitro Biological Evaluation.
    Molecules (Basel, Switzerland), 2018, 06-15, Volume: 23, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Drug Screening Assays, A

2018
Surfactant and Chaotropic Agent Assisted Sequential Extraction/On-Pellet Digestion (SCAD) for Enhanced Proteomics.
    Journal of proteome research, 2018, 08-03, Volume: 17, Issue:8

    Topics: Amino Acid Sequence; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Female; Humans; Proteins; P

2018
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Mar-01, Volume: 129

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin

2019
Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.
    Journal of enzyme inhibition and medicinal chemistry, 2019, Volume: 34, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug

2019
Chemometric modeling of breast cancer associated carbonic anhydrase IX inhibitors belonging to the ureido-substituted benzene sulfonamide class.
    Journal of enzyme inhibition and medicinal chemistry, 2014, Volume: 29, Issue:6

    Topics: Algorithms; Antigens, Neoplasm; Antineoplastic Agents; Benzene Derivatives; Breast Neoplasms; Carbon

2014
Novel all trans-retinoic Acid derivatives: cytotoxicity, inhibition of cell cycle progression and induction of apoptosis in human cancer cell lines.
    Molecules (Basel, Switzerland), 2015, May-07, Volume: 20, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line; Cell Line, Tu

2015
FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell.
    Biochemical and biophysical research communications, 2016, 05-20, Volume: 474, Issue:1

    Topics: Animals; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, D

2016
Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.
    Journal of cellular biochemistry, 2016, Volume: 117, Issue:12

    Topics: Angiogenesis Inhibitors; Apoptosis; Blotting, Western; Breast; Breast Neoplasms; Cell Proliferation;

2016
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1;

2016
Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties.
    Molecules (Basel, Switzerland), 2016, Jun-10, Volume: 21, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Screening Assays, Ant

2016
Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
    European journal of medicinal chemistry, 2016, Nov-29, Volume: 124

    Topics: Antioxidants; Apoptosis; Bacteria; Benzene; Breast Neoplasms; Cell Survival; Enzyme Inhibitors; Fema

2016
Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: A549 Cells; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Axl Receptor Tyrosine Kinase;

2016
Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
    Bioinformatics (Oxford, England), 2009, Dec-01, Volume: 25, Issue:23

    Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation,

2009
5-ureidobenzofuranone indoles as potent and efficacious inhibitors of PI3 kinase-alpha and mTOR for the treatment of breast cancer.
    Bioorganic & medicinal chemistry letters, 2010, Jun-15, Volume: 20, Issue:12

    Topics: Animals; Benzofurans; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Humans; In

2010
Radiosynthesis of [13N]dantrolene, a positron emission tomography probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia.
    Bioorganic & medicinal chemistry, 2012, Jan-01, Volume: 20, Issue:1

    Topics: Ammonia; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters;

2012
Synthesis and evaluation of 1-(substituted)-3-prop-2-ynylureas as antiangiogenic agents.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Angiogenesis Inhibitors; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Fema

2012
Chk'ing p53-deficient breast cancers.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Checkpoint Kinase 1; Female; Humans; Molecular Tar

2012
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemother

2012
Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1.
    Cancer discovery, 2012, Volume: 2, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line; Cell Li

2012
The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo.
    Molecular medicine reports, 2012, Volume: 6, Issue:4

    Topics: Animals; Apoptosis; Breast Neoplasms; Checkpoint Kinase 1; DNA Damage; Female; G2 Phase Cell Cycle C

2012
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
    Cancer research, 2012, Oct-01, Volume: 72, Issue:19

    Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Breast Neoplasms; Cell Line, Tumor

2012
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Anemia; Anemia, Myelophthisic; Antineoplastic Agents; Breast Neoplasms; Drug Therapy; Erythema; Estr

1964
HORMONAL THERAPY IN CANCER OF THE BREAST. 23. EFFECT OF 7-ALPHA-METHYL-19-NORTESTOSTERONE ACETATE AND TESTOSTERONE PROPIONATE ON CLINICAL COURSE AND HORMONAL EXCRETION.
    Cancer, 1964, Volume: 17

    Topics: 17-Ketosteroids; Acetates; Antineoplastic Agents; Bilirubin; Biomedical Research; Blood Glucose; Bre

1964
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:4

    Topics: Aminoquinolines; Animals; Animals, Genetically Modified; Antineoplastic Agents; Apoptosis; Breast Ne

2006
Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
    International journal of oncology, 2006, Volume: 29, Issue:1

    Topics: Antibiotics, Antineoplastic; Antimitotic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms

2006
Protein complexes of intermediate-sized filaments: melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics.
    Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:23

    Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Cattle; Cell Line; Cytoskeleton; Electrophores

1983
Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. Differences with anti-estrogen and estrogen.
    The Journal of biological chemistry, 1982, Aug-10, Volume: 257, Issue:15

    Topics: Breast Neoplasms; Cell Line; Centrifugation, Density Gradient; Chromatography, Gel; Estradiol; Femal

1982
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
    Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl

    Topics: Animals; Antibodies, Monoclonal; Benzoates; Breast Neoplasms; Female; Humans; Iodine Radioisotopes;

1995
Characterization of novel inhibitors of cyclin-dependent kinases.
    Biochemical and biophysical research communications, 1999, Jul-14, Volume: 260, Issue:3

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzoic Acid; Blotting, Western; Breast Neoplasms; Ce

1999
Highly sensitive mutation screening by REF with low concentrations of urea: A blinded analysis of a 2-kb region of the p53 gene reveals two common haplotypes.
    Human mutation, 1999, Volume: 14, Issue:2

    Topics: Breast Neoplasms; DNA Fingerprinting; Genes, p53; Haplotypes; Humans; Introns; Mutation; Polymorphis

1999
Taste acuity and food attitudes of selected patients with cancer.
    Journal of the American Dietetic Association, 1977, Volume: 70, Issue:4

    Topics: Adult; Aged; Attitude to Health; Breast Neoplasms; Colonic Neoplasms; Diet; Female; Fluorouracil; Fo

1977
Posthypophysectomy taste abnormalities: their relationship to remote effects of cancer.
    Cancer, 1977, Volume: 39, Issue:4

    Topics: Breast Neoplasms; Female; Humans; Hydrochloric Acid; Hypophysectomy; Male; Neoplasms; Pituitary Glan

1977
An assessment of the clinical usefulness of plasma ribonuclease assays.
    Clinica chimica acta; international journal of clinical chemistry, 1976, Oct-15, Volume: 72, Issue:2

    Topics: Acute Kidney Injury; Breast Neoplasms; Clinical Enzyme Tests; Creatinine; Humans; Multiple Myeloma;

1976
Western blotting and immunochemical detection of histones electrophoretically resolved on acid-urea-triton- and sodium dodecyl sulfate-polyacrylamide gels.
    Analytical biochemistry, 1992, Feb-01, Volume: 200, Issue:2

    Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Line; Chickens; Electrophoresis, Polyacrylamide G

1992
Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells.
    Biochemical and biophysical research communications, 1986, Feb-26, Volume: 135, Issue:1

    Topics: Binding, Competitive; Breast Neoplasms; Cell Line; Centrifugation, Density Gradient; Deoxyribonuclea

1986
Phosphate treatment of hypercalcaemia due to carcinoma.
    British medical journal, 1968, Oct-05, Volume: 4, Issue:5622

    Topics: Aged; Breast Neoplasms; Bronchial Neoplasms; Calcinosis; Cornea; Female; Humans; Hypercalcemia; Infu

1968
Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia.
    The Journal of clinical endocrinology and metabolism, 1972, Volume: 35, Issue:6

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Bronchogenic; Chlorothiazide; Cyclic AMP; Diagnosis, Diffe

1972
Demonstration of collagen in human tissues by immunofluorescence.
    Laboratory investigation; a journal of technical methods and pathology, 1972, Volume: 27, Issue:1

    Topics: Animals; Antigens; Breast; Breast Neoplasms; Collagen; Fluorescent Antibody Technique; Guanidines; H

1972
Plasma phosphate and potassium levels in the hypercalcemia of malignant disease.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:5

    Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hypercalcemia; Hyperparathyroidism; Neoplasm

1973
Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:1

    Topics: Administration, Oral; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carmustine; Female

1972
The importance of varying molecular size, differential heat and urea inactivation of phosphatase in the identification of disease patterns.
    Annals of the New York Academy of Sciences, 1969, Oct-14, Volume: 166, Issue:2

    Topics: Adult; Alkaline Phosphatase; Biliary Tract Diseases; Breast Neoplasms; Carcinoma; Chemical Phenomena

1969